Vascepa is a prescription medication used to treat high triglyceride levels in the blood. It is a type of omega-3 fatty acid that works by reducing the production of triglycerides in the liver. The medication has been approved by the FDA to reduce the risk of cardiovascular events in certain adult patient groups [2].

When it comes to combining Vascepa with blood thinners, it is important to note that there is a potential for an increased risk of bleeding. Blood thinners, such as warfarin, heparin, or aspirin, are commonly prescribed to reduce the risk of blood clots in patients with certain medical conditions. However, these medications can also increase the risk of bleeding, especially when combined with other medications that have a similar effect [3].

According to the Drug Patent Watch, there are no known drug interactions between Vascepa and blood thinners [1]. However, patients who are taking both medications should be closely monitored by their healthcare provider to ensure that their blood clotting levels remain within a safe range.

In conclusion, while there are no known drug interactions between Vascepa and blood thinners, there is still a potential for an increased risk of bleeding. Patients who are taking both medications should be closely monitored by their healthcare provider to ensure that their blood clotting levels remain within a safe range [1][2][3].

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.fda.gov/news-events/press-announcements/fda-approves-use-drug-reduce-risk-cardiovascular-events-certain-adult-patient-groups
[3] https://www.healthline.com/health/drugs/vascepa